Medicare Plan Premiums Set for Changes in 2027

Medicare plan premiums are set for modest shifts in 2027, with Medicare Advantage plans expected to decrease while Part D prescription plans are likely to see slight increases, according to the Centers for Medicare & Medicaid Services (CMS).

Starting January 1, 2027, beneficiaries enrolled in Medicare Advantage plans can expect to pay lower monthly premiums, with the average cost dropping from $14.37 in 2026 to $12. Conversely, those enrolled in stand-alone Part D prescription drug plans might see their premiums rise slightly from $35.09 to $36. This change comes amid a stable market environment, a positive indicator highlighted by John Brooks, the director of Medicare at CMS, who stresses the importance of beneficiaries assessing their plan options during the annual open enrollment period from October 15 to December 7.

Broader Implications for Policy Holders

Approximately 80% of Medicare Advantage participants are expected to keep their plans with the same or reduced premiums. In 2027, nearly all Medicare enrollees (97%) will have access to ten or more Medicare Advantage options, showing little change in the number of available plans overall (5,532 compared to 5,553 in 2026). However, the CMS did not specify how many enrollees might be impacted by plans not continuing into 2027. Insurance professionals should advise clients to closely examine changes in their options and align their selections with their healthcare needs.

Changes in Subsidies and Financial Implications

The Biden administration previously introduced a subsidy to offset rising prescription drug costs through the Inflation Reduction Act, which placed a cap on out-of-pocket expenses. However, CMS has announced the termination of this subsidy, which had cost the federal government $9.8 billion over two years. This withdrawal of support has prompted analysts to predict higher Part D prices in 2027, though CMS describes this as a return to typical market conditions.

Considerations for Industry Professionals

• Premium Adjustments: Medicare Advantage premiums are projected to decrease, enhancing plan attractiveness. Agents should consider how this pricing shift might influence client preferences.
• Drug Formulary Changes: Part D plans may alter drug formularies to manage costs, potentially affecting available prescription drugs for clients.
• Enrollment Notifications: Insurers must notify policyholders by September 30 of any changes, enabling clients to make informed decisions during open enrollment.

Strategic Impact on Insurers and Beneficiaries

For insurance carriers and brokers, the modest changes in premium pricing necessitate strategic communication to both existing and potential clients. Juliette Cubanski, a vice president at KFF, notes that low Medicare Advantage premiums play a significant role in their popularity. However, firms may navigate these lower premiums by adjusting coverage terms, such as through increased cost-sharing or reduced drug options. As open enrollment approaches, insurance professionals should prepare to guide beneficiaries through evaluating potential impacts on their healthcare coverage, ensuring that policies meet evolving needs.